In recent trading, shares of J.M. Smucker Co. (Symbol: SJM) have crossed above the average analyst 12-month target price of $112.10, changing hands for $112.33/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on
To become a "Dividend Aristocrat," a dividend paying company must accomplish an incredible feat: consistently increase shareholder dividends every year for at least 20 consecutive years. Companies with this kind of track record tend to attract a lot of investor attention — an
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itse
Brazil's central bank is requiring banks to report if they intend to pay shareholders dividends above minimum levels required by regulations or bylaws, a person with knowledge of the matter said on Monday.
(RTTNews) - Providing an update on the impact of COVID-19, Patterson Cos., Inc. (PDCO) announced Monday that it is withdrawing its financial guidance for the full year 2020, which was initiated on February 27, 2020, given the disruption of North American and international market
CVS Health Corp said that it will launch two new drive-through COVID-19 testing sites in Georgia and Rhode Island on Monday using new, faster tests than had previously been available, with up to four more locations to follow.
Medical equipment group Getinge said on Monday it was increasing its production capacity for ventilators this year by 160% from last year's levels, to 26,000 units, to meet demand spurred by the coronavirus pandemic.
(RTTNews) - Millendo Therapeutics Inc. (MLND), a clinical-stage biopharmaceutical company developing novel treatments for orphan endocrine diseases, announced Monday that it is discontinuing the development of livoletide as a potential treatment for Prader-Willi syndrome or PWS.
JPMorgan Chase & Co could consider suspending dividend for 2020 due to the ongoing coronavirus crisis, Chief Executive Officer Jamie Dimon said on Monday, even as the bank rolled out relief measures for customers and small businesses.
I hope you have your seatbelt fastened, because the spread of the coronavirus disease 2019 (COVID-19) has made the past six-plus weeks wilder than any previous bear market correction in history.
(RTTNews) - Announcing preliminary results for the first quarter of fiscal 2020 on Monday, Teledyne Technologies Inc. (TDY) said it expects to achieve record first quarter sales and earnings per share. Sales are expected to increase over 5%, including positive organic growth, to
The COVID-19 crisis isn't just costing Americans their freedom and jobs; it's also forcing millions to contemplate their own mortality. Though the majority of those infected with COVID-19 are able to recover at home, an estimated 20% need hospitalization, and in the absence of w
The U.S. dollar stalled against most currencies on Monday but continued its rise versus the Japanese yen as investors digested the fact that the rate of deaths from coronavirus in Europe was slowing while deaths in Japan and elsewhere in Asia accelerated.
Launched on 01/26/2011, the SPDR S&P Health Care Equipment ETF (XHE) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Medical Devices segment of the equity market.
(RTTNews) - Announcing additional actions in response to impact Of COVID-19, footwear retailer Genesco Inc. (GCO) announced Monday proactive steps in its efforts to significantly reduce expense, capital and inventory levels to mitigate the negative financial and operational impa
Saudi Arabia and Russia are close to a deal on oil output cuts to reduce a global glut, a top Russian oil negotiator said on Monday, but details such as how to share out production curbs remained unclear ahead of talks planned for later this week.
(RTTNews) - Molecular diagnostics company Co-Diagnostics, Inc. (CODX) announced Monday that its Logix Smart coronavirus COVID-19 test has obtained Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) to be used for the diagnosis of SARS-CoV-2.
(RTTNews) - Gilead Sciences, Inc. (GILD) and Second Genome have entered into a four-year strategic collaboration in biomarker and inflammatory bowel disease drug discovery. This will include the identification of up to five drug candidates for the treatment of inflammatory bowel
RTTNews
Checked
6 minutes 14 seconds ago
This feed is responsible for generating the rss feed related to the topic latest article